Ovarian cancer victim wins $417m payout from Johnson & Johnson

Share this post

Court orders firm to compensate woman who claims her cancer was linked to using talc products for feminine hygiene

A jury has ordered Johnson & Johnson (J&J) to pay $417m (£323m) to a woman who claimed she developed ovarian cancer after using the company’s talc-based products such as Johnson’s Baby Powder for feminine hygiene.

Related: Is it safe to use talcum powder?

Continue reading…

This post was syndicated from Health | The Guardian. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply